Published in Clin Pharmacol Ther on October 27, 2010
Aversive and reinforcing opioid effects: a pharmacogenomic twin study. Anesthesiology (2012) 2.85
κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. Trends Neurosci (2012) 1.29
Relapse prevention for addictive behaviors. Subst Abuse Treat Prev Policy (2011) 1.29
Candidate gene studies of a promising intermediate phenotype: failure to replicate. Neuropsychopharmacology (2012) 1.08
Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J Pain (2013) 1.06
Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids. Neuropsychopharmacology (2011) 0.96
Linkage analysis followed by association show NRG1 associated with cannabis dependence in African Americans. Biol Psychiatry (2012) 0.88
Multigenerational and transgenerational inheritance of drug exposure: The effects of alcohol, opiates, cocaine, marijuana, and nicotine. Prog Biophys Mol Biol (2015) 0.87
Genetics of GABAergic signaling in nicotine and alcohol dependence. Hum Genet (2011) 0.87
Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment. Addict Sci Clin Pract (2010) 0.85
Future pharmacological treatments for substance use disorders. Br J Clin Pharmacol (2014) 0.83
Genome-wide time-to-event analysis on smoking progression stages in a family-based study. Brain Behav (2016) 0.81
Advances in Electrophysiological Research. Alcohol Res (2015) 0.81
Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study. PLoS One (2013) 0.81
Genome-environmental risk assessment of cocaine dependence. Front Genet (2012) 0.81
Hnrnph1 Is A Quantitative Trait Gene for Methamphetamine Sensitivity. PLoS Genet (2015) 0.81
Methamphetamine-induced conditioned place preference in LG/J and SM/J mouse strains and an F45/F46 advanced intercross line. Front Genet (2012) 0.80
Behavioral architecture of opioid reward and aversion in C57BL/6 substrains. Front Behav Neurosci (2015) 0.80
Introduction to deep sequencing and its application to drug addiction research with a focus on rare variants. Mol Neurobiol (2013) 0.79
Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds. Addict Sci Clin Pract (2014) 0.79
The heritability of oxycodone reward and concomitant phenotypes in a LG/J × SM/J mouse advanced intercross line. Addict Biol (2012) 0.79
Current perspectives on the neurobiology of drug addiction: a focus on genetics and factors regulating gene expression. ISRN Neurol (2012) 0.76
Genetic Polymorphism in the Promoter Region of Serotonin Transporter: Implications for Ethanol Abuse in Children and Adolescents. J Can Acad Child Adolesc Psychiatry (2016) 0.75
Factors Associated With Smoking Status among HIV-Positive Patients in Routine Clinical Care. J AIDS Clin Res (2015) 0.75
CYP2A6 Polymorphisms May Strengthen Individualized Treatment for Nicotine Dependence. Scientifica (Cairo) (2015) 0.75
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A (2009) 54.68
Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science (2009) 16.35
Single-molecule sequencing of an individual human genome. Nat Biotechnol (2009) 8.35
How to interpret a genome-wide association study. JAMA (2008) 7.54
Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry (2008) 6.73
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature (1998) 6.27
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science (2004) 5.94
The genetics of addictions: uncovering the genes. Nat Rev Genet (2005) 5.05
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology (2003) 3.66
Cancer genomics: small RNAs with big impacts. Nature (2005) 2.55
Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction (2008) 2.29
Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci (2008) 2.27
Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15. Hum Mol Genet (2009) 2.22
The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med (2009) 2.20
Epigenetic mechanisms in drug addiction. Trends Mol Med (2008) 2.14
Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res (2001) 1.85
The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics (2006) 1.83
Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A (1999) 1.81
The neurobiology of addictive disorders. Clin Neuropharmacol (2009) 1.76
New insights into the genetics of addiction. Nat Rev Genet (2009) 1.70
Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics (2007) 1.56
Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry (2007) 1.56
Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob Control (2004) 1.47
Genetic influences on alcohol consumption patterns and problem drinking: results from the Australian NH&MRC twin panel follow-up survey. Ann N Y Acad Sci (1994) 1.47
Genome-wide association studies and human disease: from trickle to flood. JAMA (2009) 1.44
Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res (2008) 1.43
Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry (2009) 1.37
Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25. Trends Pharmacol Sci (2009) 1.35
Overview of the pharmacogenomics of cigarette smoking. Pharmacogenomics J (2007) 1.35
Concordance of different measures of nicotine dependence: two pilot studies. Addict Behav (2004) 1.24
Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology (2008) 1.23
Microarray studies of psychostimulant-induced changes in gene expression. Addict Biol (2005) 1.22
Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. Behav Brain Res (2008) 1.14
How will GINA influence participation in pharmacogenomics research and clinical testing? Clin Pharmacol Ther (2009) 1.14
Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res (2009) 1.11
Modeling of environmental effects in genome-wide association studies identifies SLC2A2 and HP as novel loci influencing serum cholesterol levels. PLoS Genet (2010) 1.10
Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet Genomics (2009) 1.10
Nicotine modulates expression of miR-140*, which targets the 3'-untranslated region of dynamin 1 gene (Dnm1). Int J Neuropsychopharmacol (2008) 1.08
Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene. Mol Interv (2007) 1.08
Gene-environment interactions and alcohol use and dependence: current status and future challenges. Addiction (2009) 1.05
Role of a functional human gene polymorphism in stress responsivity and addictions. Clin Pharmacol Ther (2008) 1.01
Invited commentary: efficient testing of gene-environment interaction. Am J Epidemiol (2008) 1.00
Opiate and cocaine addiction: from bench to clinic and back to the bench. Curr Opin Pharmacol (2009) 0.99
The art of recruitment: the foundation of family and linkage studies of psychiatric illness. Fam Process (1998) 0.98
Pharmacogenetic treatments for drug addiction: alcohol and opiates. Am J Drug Alcohol Abuse (2008) 0.98
Molecular genetics of alcohol dependence and related endophenotypes. Curr Genomics (2008) 0.90
Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. Annu Rev Pharmacol Toxicol (2010) 0.88
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment. Pharmacogenomics J (2008) 0.87
Detection of genetic association and a functional polymorphism of dynamin 1 gene with nicotine dependence in European and African Americans. Neuropsychopharmacology (2008) 0.85
A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. Nicotine Tob Res (2008) 0.82
Synergistic effects of the dopaminergic and glutamatergic system on hippocampal volume in alcohol-dependent patients. Biol Psychol (2008) 0.79
A review of smoking cessation interventions. MedGenMed (2005) 0.78
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science (1981) 23.67
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A (2001) 9.42
Genetic influences on brain structure. Nat Neurosci (2001) 8.39
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum (2000) 6.88
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA (1989) 6.68
Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet (1998) 5.24
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
Relationship of leisure-time physical activity and mortality: the Finnish twin cohort. JAMA (1998) 4.35
Narcotic blockade. Arch Intern Med (1966) 3.80
Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet (1998) 3.37
Gel protein stains: silver stain. Methods Enzymol (1984) 3.18
Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res (2000) 3.09
Ancestral Asian source(s) of new world Y-chromosome founder haplotypes. Am J Hum Genet (1999) 2.89
Relative effect of genetic and environmental factors on body height: differences across birth cohorts among Finnish men and women. Am J Public Health (2000) 2.86
Diagnosis of twin zygosity by mailed questionnaire. Hum Hered (1978) 2.85
Ocular retardation mouse caused by Chx10 homeobox null allele: impaired retinal progenitor proliferation and bipolar cell differentiation. Nat Genet (1996) 2.75
The new drugs (chlorpromazine & reserpine): administrative aspects. 1956. Psychiatr Serv (2000) 2.58
Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion. Clin Pharmacol Ther (2008) 2.49
A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet (1998) 2.44
A rapid sensitive silver stain for polypeptides in polyacrylamide gels. Anal Biochem (1981) 2.42
The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry (1998) 2.39
Polymorphic admixture typing in human ethnic populations. Am J Hum Genet (1994) 2.37
Silver staining methods for polyacrylamide gel electrophoresis. Methods Enzymol (1983) 2.36
Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol (1999) 2.35
Breakfast skipping and health-compromising behaviors in adolescents and adults. Eur J Clin Nutr (2003) 2.35
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry (2000) 2.32
Snoring as a risk factor for ischaemic heart disease and stroke in men. Br Med J (Clin Res Ed) (1987) 2.31
Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry (2005) 2.29
Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology (2000) 2.28
Mortality after bereavement: a prospective study of 95,647 widowed persons. Am J Public Health (1987) 2.25
Alzheimer's disease in Finnish twins. Lancet (1996) 2.25
The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedures, and research program. Prog Clin Biol Res (1978) 2.24
The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry (2010) 2.23
Prospective study of asthma in relation to smoking habits among 14,729 adults. Thorax (1988) 2.22
Dual origins of Finns revealed by Y chromosome haplotype variation. Am J Hum Genet (1998) 2.21
Self-reported life satisfaction and 20-year mortality in healthy Finnish adults. Am J Epidemiol (2000) 2.19
The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18
Nicotine metabolism defect reduces smoking. Nature (1998) 2.17
Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit. Nature (1986) 2.13
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry (2003) 2.12
The genetics of smoking persistence in men and women: a multicultural study. Behav Genet (1999) 2.11
Snoring as a risk factor for hypertension and angina pectoris. Lancet (1985) 2.09
The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am J Hum Genet (2000) 2.07
Gene-environment interaction in patterns of adolescent drinking: regional residency moderates longitudinal influences on alcohol use. Alcohol Clin Exp Res (2001) 2.07
A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther (1997) 2.06
A population-based study of bronchial asthma in adult twin pairs. Chest (1991) 2.04
Influence of psychological factors on risk of temporomandibular disorders. J Dent Res (2007) 2.02
Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet (1997) 2.02
Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav (2008) 2.00
The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord (1996) 1.98
Genetic influences on use and abuse of alcohol: a study of 5638 adult Finnish twin brothers. Alcohol Clin Exp Res (1987) 1.93
The utility of the non-human primate; model for studying gene by environment interactions in behavioral research. Genes Brain Behav (2003) 1.91
Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system. Cell (1987) 1.90
Life satisfaction and suicide: a 20-year follow-up study. Am J Psychiatry (2001) 1.90
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry (2006) 1.89
Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol (1986) 1.88
Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. Mol Psychiatry (2007) 1.88
Variations in expression of mutant beta actin accompanying incremental increases in human fibroblast tumorigenicity. Cell (1982) 1.86
Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res (2001) 1.85
Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol (1998) 1.84
Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers. Clin Pharmacol Ther (2009) 1.83
The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. JAMA (1993) 1.83
Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. Mol Pharmacol (2000) 1.82
Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care (2001) 1.82
Drinking or abstaining at age 14? A genetic epidemiological study. Alcohol Clin Exp Res (2001) 1.81
Isolation of a clone coding for the alpha-subunit of a mouse acetylcholine receptor. J Neurosci (1985) 1.80
Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc Natl Acad Sci U S A (1987) 1.79
1991 Volvo Award in clinical sciences. Smoking and lumbar intervertebral disc degeneration: an MRI study of identical twins. Spine (Phila Pa 1976) (1991) 1.79
Pubertal timing and substance use: associations between and within families across late adolescence. Dev Psychol (2000) 1.78
An Asian-Native American paternal lineage identified by RPS4Y resequencing and by microsatellite haplotyping. Ann Hum Genet (1999) 1.78
Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ (1998) 1.77
The cheetah is depauperate in genetic variation. Science (1983) 1.75
Exploring gene-environment interactions: socioregional moderation of alcohol use. J Abnorm Psychol (2001) 1.75
Repressive control of potassium transport in Escherichia coli. Biochim Biophys Acta (1966) 1.73
Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry (1998) 1.72
Genetic factors and osteoporotic fractures in elderly people: prospective 25 year follow up of a nationwide cohort of elderly Finnish twins. BMJ (1999) 1.72
Osteoarthritis of weight bearing joints of lower limbs in former élite male athletes. BMJ (1994) 1.72
Quantitative-trait-locus analysis of body-mass index and of stature, by combined analysis of genome scans of five Finnish study groups. Am J Hum Genet (2001) 1.72
The genetic and environmental influences on childhood obesity: a systematic review of twin and adoption studies. Int J Obes (Lond) (2009) 1.71
Rating of medication influences (ROMI) scale in schizophrenia. Schizophr Bull (1994) 1.71
Rifampin-induced methadone withdrawal. N Engl J Med (1976) 1.70
An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol Behav (1996) 1.70
Lifestyle, stress, and genes in peptic ulcer disease: a nationwide twin cohort study. Arch Intern Med (1998) 1.69
Increased life expectancy of world class male athletes. Med Sci Sports Exerc (1993) 1.67
Maternal transmission in Huntington's disease. Lancet (1983) 1.64
Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest (1996) 1.64
Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes. Oncogene (1996) 1.62
Correlates of posttraumatic epilepsy 35 years following combat brain injury. Neurology (2010) 1.62
Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers. A study of monozygotic twin pairs discordant for smoking. Circulation (1988) 1.60
Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol (2011) 1.59
Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Engl J Med (1977) 1.59
Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry (2006) 1.59
Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Clin Pharmacol Ther (2010) 1.59
On the complexity of protein folding. J Comput Biol (1998) 1.59
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry (2004) 1.56
Prefrontal cortex lesions and MAO-A modulate aggression in penetrating traumatic brain injury. Neurology (2011) 1.56
Intragenic polymorphisms of the vitamin D receptor gene associated with intervertebral disc degeneration. Spine (Phila Pa 1976) (1998) 1.56
Magnetic fields of high voltage power lines and risk of cancer in Finnish adults: nationwide cohort study. BMJ (1996) 1.55
Development of alcohol-associated cues and cue-induced brain activation in alcoholics. Eur Psychiatry (2002) 1.54